Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer ; volume:18 ; number:1 ; day:29 ; month:10 ; year:2018 ; pages:1-8 ; date:12.2018
BMC cancer ; 18, Heft 1 (29.10.2018), 1-8, 12.2018
- Urheber
-
Gass, Paul
Lux, Michael P.
Rauh, Claudia
Hein, Alexander
Bani, Mayada R.
Fiessler, Cornelia
Hartmann, Arndt
Häberle, Lothar
Pretscher, Jutta
Erber, Ramona
Wachter, David L.
Schulz-Wendtland, Rüdiger
Beckmann, Matthias W.
Fasching, Peter Andreas
Wunderle, Marius
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-018-4925-1
- URN
-
urn:nbn:de:101:1-2018121722470466311855
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gass, Paul
- Lux, Michael P.
- Rauh, Claudia
- Hein, Alexander
- Bani, Mayada R.
- Fiessler, Cornelia
- Hartmann, Arndt
- Häberle, Lothar
- Pretscher, Jutta
- Erber, Ramona
- Wachter, David L.
- Schulz-Wendtland, Rüdiger
- Beckmann, Matthias W.
- Fasching, Peter Andreas
- Wunderle, Marius
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods
Breast Cancer and Genetic BRCA1/2 Testing in Routine Clinical Practice: Why, When and For Whom?
Risk, Prediction and Prevention of Hereditary Breast Cancer – Large-Scale Genomic Studies in Times of Big and Smart Data
Quality Assured Health Care in Certified Breast Centers and Improvement of the Prognosis of Breast Cancer Patients
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospitalbased case–control study
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study
Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma
Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients – a Survey Among Physicians
Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer center
HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods
Breast Cancer and Genetic BRCA1/2 Testing in Routine Clinical Practice: Why, When and For Whom?
Risk, Prediction and Prevention of Hereditary Breast Cancer – Large-Scale Genomic Studies in Times of Big and Smart Data
Quality Assured Health Care in Certified Breast Centers and Improvement of the Prognosis of Breast Cancer Patients
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospitalbased case–control study
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study
Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma
Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients – a Survey Among Physicians
Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer center
HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment
Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer
Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods
Breast Cancer and Genetic BRCA1/2 Testing in Routine Clinical Practice: Why, When and For Whom?
Risk, Prediction and Prevention of Hereditary Breast Cancer – Large-Scale Genomic Studies in Times of Big and Smart Data
Quality Assured Health Care in Certified Breast Centers and Improvement of the Prognosis of Breast Cancer Patients
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospitalbased case–control study
Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study
Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma
Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients – a Survey Among Physicians
Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer center